Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.2M Sell
318,655
-56,180
-15% -$12.1M 1.23% 23
2026
Q1
$81.5M Sell
374,835
-5,634
-1% -$1.25M 1.4% 19
2025
Q4
$86.9M Buy
380,469
+2,481
+0.7% +$565K 1.5% 18
2025
Q3
$87.5M Buy
377,988
+1,478
+0.4% +$301K 1.55% 19
2025
Q2
$69.9M Buy
376,510
+4,316
+1% +$802K 1.33% 20
2025
Q1
$78M Buy
372,194
+82,030
+28% +$15.9M 1.53% 19
2024
Q4
$51.6M Buy
290,164
+77,889
+37% +$14.3M 0.96% 25
2024
Q3
$41.9M Buy
212,275
+78,551
+59% +$14.7M 0.75% 40
2024
Q2
$22.9M Buy
133,724
+3,428
+3% +$568K 0.93% 38
2024
Q1
$23.7M Buy
130,296
+8,743
+7% +$1.51M 0.99% 37
2023
Q4
$18.8M Sell
121,553
-3,883
-3% -$566K 0.86% 43
2023
Q3
$18.7M Buy
125,436
+266
+0.2% +$39K 0.93% 39
2023
Q2
$16.9M Buy
125,170
+19,905
+19% +$2.92M 0.8% 52
2023
Q1
$16.8M Buy
105,265
+7,758
+8% +$1.19M 0.84% 51
2022
Q4
$15.8M Buy
97,507
+450
+0.5% +$69K 0.84% 49
2022
Q3
$13M Buy
97,057
+1,218
+1% +$175K 0.74% 52
2022
Q2
$14.7M Buy
95,839
+72,654
+313% +$11.1M 0.78% 53
2022
Q1
$3.76M Buy
23,185
+14,713
+174% +$2.14M 0.17% 91
2021
Q4
$1.15M Buy
8,472
+109
+1% +$12.9K 0.05% 129
2021
Q3
$902K Hold
8,363
0.04% 129
2021
Q2
$942K Sell
8,363
-93
-1% -$10.5K 0.05% 131
2021
Q1
$915K Sell
8,456
-539
-6% -$57.7K 0.05% 131
2020
Q4
$964K Sell
8,995
-29
-0.3% -$2.79K 0.05% 120
2020
Q3
$791K Sell
9,024
-139
-2% -$13.1K 0.05% 120
2020
Q2
$900K Sell
9,163
-204
-2% -$18K 0.06% 115
2020
Q1
$714K Sell
9,367
-561
-6% -$47.8K 0.05% 119
2019
Q4
$879K Sell
9,928
-1,923
-16% -$160K 0.05% 112
2019
Q3
$898K Sell
11,851
-2,653
-18% -$182K 0.06% 110
2019
Q2
$1.05M Sell
14,504
-14,103
-49% -$1.11M 0.07% 108
2019
Q1
$2.31M Sell
28,607
-128,280
-82% -$10.5M 0.15% 94
2018
Q4
$14.5M Sell
156,887
-1,892
-1% -$166K 1.08% 37
2018
Q3
$15M Buy
158,779
+1,210
+0.8% +$115K 0.98% 47
2018
Q2
$14.6M Buy
157,569
+4,980
+3% +$486K 1% 43
2018
Q1
$14.4M Buy
152,589
+99,675
+188% +$10.9M 1.01% 40
2017
Q4
$5.12M Sell
52,914
-10,064
-16% -$948K 0.34% 79
2017
Q3
$5.6M Sell
62,978
-441
-0.7% -$33.6K 0.4% 78
2017
Q2
$4.6M Buy
63,419
+2,112
+3% +$142K 0.34% 80
2017
Q1
$4M Sell
61,307
-1,158
-2% -$72.8K 0.3% 83
2016
Q4
$3.91M Buy
62,465
+342
+0.6% +$20.9K 0.3% 79
2016
Q3
$3.92M Sell
62,123
-16,592
-21% -$1.07M 0.31% 79
2016
Q2
$4.87M Buy
78,715
+2,179
+3% +$133K 0.39% 78
2016
Q1
$4.37M Buy
76,536
+699
+0.9% +$39K 0.36% 77
2015
Q4
$4.49M Sell
75,837
-376
-0.5% -$21.7K 0.37% 73
2015
Q3
$4.15M Buy
76,213
+532
+0.7% +$34.6K 0.36% 73
2015
Q2
$5.08M Sell
75,681
-450
-0.6% -$29.4K 0.41% 71
2015
Q1
$4.46M Buy
76,131
+9,175
+14% +$554K 0.36% 74
2014
Q4
$4.38M Buy
66,956
+175
+0.3% +$11K 0.35% 71
2014
Q3
$3.86M Buy
66,781
+11,636
+21% +$646K 0.31% 72
2014
Q2
$3.11M Buy
55,145
+974
+2% +$51.1K 0.25% 74
2014
Q1
$2.78M Buy
54,171
+35,020
+183% +$1.77M 0.23% 73
2013
Q4
$1.01M Sell
19,151
-2,082
-10% -$102K 0.09% 105
2013
Q3
$950K Sell
21,233
-1,427
-6% -$63.3K 0.09% 110
2013
Q2
$937K Buy
+22,660
New +$991K 0.09% 107

Other funds holding ABBV

Eastern Bank's ABBV Position: Q2 2026 in Review

Eastern Bank reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $12.1M and leaving 318,655 shares worth $80.2M. The position accounts for 1.23% of the portfolio, ranked #23.

Eastern Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $87.5M in Q3 2025. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eastern Bank held 318,655 shares of AbbVie worth $80.2M as of Q2 2026.
  • Eastern Bank sold 56,180 AbbVie shares in Q2 2026, an estimated $12.1M.
  • AbbVie made up 1.23% of Eastern Bank's portfolio in Q2 2026, its #23 holding.
  • Eastern Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Eastern Bank's AbbVie position peaked at $87.5M in Q3 2025.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.